Ivy Yiyi Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ivy Yiyi Zhu has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Alec Lloyd
School of Molecular and Cellular Biology, University of Leeds, Leeds LS2 9JT, U.K
1 shared publicationAysha Divan
School of Molecular and Cellular Biology, University of Leeds, Leeds LS2 9JT, U.K
1 shared publication- Christopher J. Brown
Institute of Molecular and Cell Biology, Singapore, Singapore
1 shared publication - Dhananjay Jade
School of Molecular & Cellular Biology, University of Leeds, Leeds LS2 9JT, UK
1 shared publication - Elton Zeqiraj
Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK
1 shared publication - Michael A. Harrison
School of Biomedical Sciences, University of Leeds, Leeds LS2 9JT, UK
1 shared publication
Latest Publications
- Open Access
- 17 February 2025
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 482 (04) , 241-262
Structure and function of MDM2 and MDM4 in health and disease
Both mouse double-minute 2 (MDM2), an E3 ubiquitin ligase, and its closely related paralog, MDM4, which lacks E3 activity, play central roles in cellular homeostasis. MDM-linked dysfunction is associated with an increased risk of oncogenesis, primarily through targeting the tumor suppressor protein p53 for ubiquitination and degradation. Recent studies have revealed multifaceted roles of MDM proteins that are p53 independent with implications for their oncogenic properties. This review aims to provide an overview of MDM2 and MDM4, by assessing gene and protein structure and implications for protein–protein interactions and functions in cell and animal physiology. We also explore MDM2 and MDM4 role(s) in angiogenesis, a critical feature of solid tumor growth and progression. Finally, we discuss the current landscape in the development of MDM2 and MDM4 inhibitors for cancer therapy.
- 17 February 2025
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 482 (04) , 241-262
Open AccessStructure and function of MDM2 and MDM4 in health and disease
Both mouse double-minute 2 (MDM2), an E3 ubiquitin ligase, and its closely related paralog, MDM4, which lacks E3 activity, play central roles in cellular homeostasis. MDM-linked dysfunction is associated with an increased risk of oncogenesis, primarily through targeting the tumor suppressor protein p53 for ubiquitination and degradation. Recent studies have revealed multifaceted roles of MDM proteins that are p53 independent with implications for their oncogenic properties. This review aims to provide an overview of MDM2 and MDM4, by assessing gene and protein structure and implications for protein–protein interactions and functions in cell and animal physiology. We also explore MDM2 and MDM4 role(s) in angiogenesis, a critical feature of solid tumor growth and progression. Finally, we discuss the current landscape in the development of MDM2 and MDM4 inhibitors for cancer therapy.